FET PET/CT Imaging for Cushing Disease

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Recruiting Early Phase 1 Interventional Study
Cushing Disease Pituitary Adenoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Diagnostic
Participants needed
50 (estimated)
Sponsor
Mayo Clinic · Other
Who this trial is looking for

This trial is looking for adults with a specific type of hormone disorder called ACTH-dependent Cushing disease. Participants will undergo special imaging to help locate a pituitary tumor before surgery.

Are You a Good Fit for This Trial?
Rules you out Autoimmune disorders

You may be able to join if

  • I have been diagnosed with ACTH-dependent Cushing disease.
  • I have not had any pituitary surgery before.
  • I plan to have surgery to remove the tumor.
  • I have no issues that prevent me from having a PET/CT scan.
  • I have had a pituitary MRI within the last 3 months, or I will have one before the imaging.
  • I am 18 years or older.
  • I can give my informed consent.

You may not be able to join if

  • I am pregnant.
  • I refuse to use effective birth control during the study.
  • I need to have surgery right away that cannot wait for this trial.
  • I have an infection that needs treatment.
  • I have a serious health condition that could affect my safety or the study.
  • I have been diagnosed with an autoimmune disorder.
  • I have taken any other experimental drug in the past 28 days.
  • I am breastfeeding and cannot wait to discard milk for 24 hours after the FET injection.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this research is to evaluate the performance \[sensitivity, specificity, accuracy\] of FET PET/CT imaging to detect ACTH-secreting pituitary adenoma, using operative findings and histopathology as truth standard.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients must meet ALL criteria listed below for entry: * Biochemically diagnosed ACTH-dependent Cushing disease. * No previous pituitary surgery. * Planned to undergo pituitary surgery for localization/resection of adenoma. * No contraindications for PET/CT. * Recent (within 3…
Contacts

Casey R McAdam, CCRP

507-293-0505

McAdam.Casey@mayo.edu

CONTACT